Chimerix Valuation
| CMRXDelisted Stock | USD 8.54 0.01 0.12% |
At this time, the firm appears to be overvalued. Chimerix shows a prevailing Real Value of $6.25 per share. The current price of the firm is $8.54. Our model approximates the value of Chimerix from analyzing the firm fundamentals such as Return On Equity of -0.56, operating margin of (430.74) %, and Shares Outstanding of 93.8 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Chimerix's price fluctuation is very steady at this time. Calculation of the real value of Chimerix is based on 3 months time horizon. Increasing Chimerix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chimerix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chimerix Stock. However, Chimerix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.54 | Real 6.25 | Hype 8.54 |
The intrinsic value of Chimerix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chimerix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Chimerix helps investors to forecast how Chimerix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chimerix more accurately as focusing exclusively on Chimerix's fundamentals will not take into account other important factors: About Chimerix Valuation
Our relative valuation model uses a comparative analysis of Chimerix. We calculate exposure to Chimerix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chimerix's related companies.Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Chimerix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 89.7 M | |
| Forward Price Earnings | 1.2136 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Chimerix Stock
If you are still planning to invest in Chimerix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chimerix's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |